marzo 27, 2017

Patents

SIIT has a long history of innovation. Innovation is the hearth of our company and is the key to SIIT’s success. It depends on creative inventors group , who propose technologies, product concepts, solutions and benefit that address on consumer needs.

Patenting is a mean to protect our innovation and to sustain and expand SIIT competitive advantage. To this aim the Research & Development group make an important contribution to SIIT’s patent portfolio each year, and supports SIIT’s product portfolio advancing SIIT’s leadership in Health solutions.

 

TECHNOLOGIES

 

FLOATING SYSTEM FOR THE TREATMENT OF GASTRIC DISORDERS

EP3067042 (A1)
New  two-layer mucoadhesive floating tablet to obtain controlled gastric release for the treatment of gastric disorders

 

MEDICINAL PREPARATION BASED ON DIOSMECTITE

CY1119636 (T1)
An innovative Ready-to-use oral  suspension containing micronized particles of diosmectite and karaya gum for the treatment of diarrhoea

 

 A SPRAYABLE OILY COMPOSITION BASED ON LIPOSOLUBLE VITAMINS OF THE GROUP D AND USE THEREOF

EP2942050 (A1)
An innovative oil-based spray to deliver vitamin D for the treatment of disorders associated to vitamin deficiencies.

 

 MULTILAYER TABLET FOR ADMINISTRATION OF MAGNESIUM

EP3357492 (A1)
An original multilayer tablet for a time and site-controlled release of magnesium, used to treat magnesium deficiency

 

FORMULAZIONI CONTENENTI MELATONINA A RILASCIO PULSATILE O SEQUENZIALE E PROCEDIMENTO PER LA LORO PREPARAZIONE

FORMULATIONS WITH MELATONIN WITH PULSATIL OR SEQUENTIAL RELEASE AND PREPARATION METHOD

MI2011A000332
Composition with multilayers tablet for time-controlled release of melatonin, a rapid layer release in 5 minutes and a slow layer within 4 hours after the intake

 

COMPLESSO DI INCLUSIONE TRA UNA CICLODESTRINA E UN OLIO VEGETALE E SUO IMPIEGO

INCLUSION COMPLEX BASED ON CYCLODEXTRIN AND VEGETABLE OIL AND ITS USE

102011901921888
New composition based on cyclodextrin and vegetable oil

 

FINISHED PRODUCTS

 

COMPOSITION FOR FLUIDIZING MUCUS COMPRISING CHITOSAN AND COPOLYMERS

EP2942063 (A1)
An innovative nasal spray containing chitosan from vegetable source for oral or topical use for treatment of common cold, flu, nasal infections, rhinitis, allergic rhinitis.

 

ORAL COMPOSITIONS FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE

EP3184115 (A1)
An innovative product based on the association of tamarind extract, alginic acid and salt- carbonate and/or hydrogen carbonate for the treatment of gastroesophageal reflux disease and pyrosis

 

BODY WEIGHT CONTROL PREPARATION BASED ON CHITOSAN AND CELLULOSE

EP3225239 (A1)
New formulation based on polysaccharides  able to capture fats.  The synergism action of vegetal chitosan, able to bind fatty acids, and powdered cellulose, able to jellified, ensures efficacy in the control of obesity, weight and cholesterol and triglycerides

 

COMPOSITIONS CONTAINING PHASEOLUS VULGARIS EXTRACT AND ALPINIA OFFICINARUM EXTRACT FOR THE PREVENTION AND TREATMENT OF OBESITY AND TYPE II DIABETES

EP1923067 (A1)
New compositions based on Phaseolus vulgaris extract and Alpinia officinarum extract for the prevention and treatment of obesity and type II diabetes

 

 ANTICARIES COMPOSITIONS CONTAINING PHASEOLAMIN

US2006257332 (A1)
Innovative compositions based on  salivar ptyalin inhibitors with anti-inflammatory, soothing, abrasive, antibacterial action

 

TOPICAL VAGINAL PHARMACEUTICAL COMPOSITIONS

SI1911455 (T1)
Innovative topical vaginal formulation based on lactobacilli, lactic acid and extract of garlic  for vaginal infections

 

COMPOSITIONS BASED ON PREBIOTIC AND IMMUNOGENIC INGREDIENTS FOR THE PREVENTION AND TREATMENT OF GASTROENTERIC DISORDERS CAUSED BY DYSBIOSIS AND/OR ALTERATIONS OF THE NORMAL INTESTINAL FLORA

EP2014181 (A2)
New compositions containing bifidogenic and lactogenic prebiotic ingredients and immunogenic ingredients able to promote the proliferation and colonisation of bifidobacteria and lactic acid bacteria in the intestine, for the prevention and treatment of gastroenteric disorders.



COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF VERTIGO AND TINNITUS INCLUDING CITICOLINE, GINKGO BILOBA EXTRACT AND DIMERIC FLAVONES OF GINKGO BILOBA

EP2018868 (A1)
Innovative formulation containing: citicoline, Ginkgo biloba extract; and dimeric flavones of Ginkgo biloba; for the treatment and prevention of vertigo and tinnitus.

 

GASTROPROTECTED FORMULATIONS CONTAINING ALPH-AMYLASE INHIBITORS

US2005186278 (A1)
Gastroresistant formulations with enteric coating based on phaseolamin, an inhibitor of alpha-amylase

 

FORMULAZIONI ORALI CONTENENTI ESTRATTI DI OLIVELLO SPINOSO

ORAL FORMULATIONS WITH BUCKTHORN EXTRACT

MI2014A001683
Innovative formulation with buckthorn extract for the wellness of immunitary system

 

COMPOSIZIONI ANTIEMETICHE A BASE DI ESTRATTI E DI VITAMINA B6

ANTIEMATIC COMPOSITION BASED ON VEGETAL EXTRACT AND VITAMIN B6

MI2004A000289
New composition based on vegetal extract and vitamin B6 with antiemetic properties

Utilizzando il sito, accetti l'utilizzo dei cookie da parte nostra. maggiori informazioni

Questo sito utilizza i cookie per fornire la migliore esperienza di navigazione possibile. Continuando a utilizzare questo sito senza modificare le impostazioni dei cookie o cliccando su "Accetta" permetti il loro utilizzo.

Chiudi